The inflammation-targeting therapy Dupixent improved symptoms for patients with COPD, results that could propel the blockbuster medicine into a massive new market.
Comments
(゚д゚)
There's nothing here…
The inflammation-targeting therapy Dupixent improved symptoms for patients with COPD, results that could propel the blockbuster medicine into a massive new market.